Chunqing Guo

4.1k total citations · 2 hit papers
66 papers, 2.9k citations indexed

About

Chunqing Guo is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Chunqing Guo has authored 66 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Immunology, 34 papers in Molecular Biology and 25 papers in Oncology. Recurrent topics in Chunqing Guo's work include Immunotherapy and Immune Responses (16 papers), Immune cells in cancer (11 papers) and CAR-T cell therapy research (9 papers). Chunqing Guo is often cited by papers focused on Immunotherapy and Immune Responses (16 papers), Immune cells in cancer (11 papers) and CAR-T cell therapy research (9 papers). Chunqing Guo collaborates with scholars based in United States, China and India. Chunqing Guo's co-authors include Xiang‐Yang Wang, Paul B. Fisher, John R. Subjeck, Xiaofei Yu, Devanand Sarkar, Huanfa Yi, Masoud H. Manjili, Daming Zuo, Xianjun Fang and Yibao Ma and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Chunqing Guo

64 papers receiving 2.8k citations

Hit Papers

Fatty acid oxidation: An emerging facet of metabolic tran... 2018 2026 2020 2023 2018 2025 100 200 300

Peers

Chunqing Guo
Jun Wei China
Chunqing Guo
Citations per year, relative to Chunqing Guo Chunqing Guo (= 1×) peers Jun Wei

Countries citing papers authored by Chunqing Guo

Since Specialization
Citations

This map shows the geographic impact of Chunqing Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chunqing Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chunqing Guo more than expected).

Fields of papers citing papers by Chunqing Guo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chunqing Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chunqing Guo. The network helps show where Chunqing Guo may publish in the future.

Co-authorship network of co-authors of Chunqing Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Chunqing Guo. A scholar is included among the top collaborators of Chunqing Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chunqing Guo. Chunqing Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guo, Chunqing, Xiaoyan Deng, Anthony C. Faber, et al.. (2024). The Innate Immune System and the TRAIL–Bcl-XL Axis Mediate a Sex Bias in Lung Cancer and Confer a Therapeutic Vulnerability in Females. Cancer Research. 84(24). 4140–4155. 2 indexed citations
2.
Ghosh, Chinmoy, Zheng Liu, Chunqing Guo, et al.. (2024). Type I gamma phosphatidylinositol phosphate 5-kinase i5 controls cell sensitivity to interferon. Developmental Cell. 59(8). 1028–1042.e5. 2 indexed citations
3.
Maji, Santanu, Amit Kumar, Praveen Bhoopathi, et al.. (2023). Dual Targeting of the PDZ1 and PDZ2 Domains of MDA-9/Syntenin Inhibits Melanoma Metastasis. Molecular Cancer Therapeutics. 22(10). 1115–1127. 4 indexed citations
4.
Chen, Chunxu, et al.. (2023). The Pleiotropic Ubiquitin-Specific Peptidase 16 and Its Many Substrates. Cells. 12(6). 886–886. 8 indexed citations
5.
Liu, Zheng, Wenjie Liu, Wei Wang, et al.. (2023). CPT1A-mediated fatty acid oxidation confers cancer cell resistance to immune-mediated cytolytic killing. Proceedings of the National Academy of Sciences. 120(39). e2302878120–e2302878120. 58 indexed citations
6.
Guo, Chunqing, Wenjie Liu, Zheng Liu, et al.. (2023). Scavenger receptor a is a major homeostatic regulator that restrains drug-induced liver injury. Hepatology. 78(1). 45–57. 8 indexed citations
7.
He, Hongliang, Chunqing Guo, Wenjie Liu, et al.. (2022). Engineering nanostructured pure cancer cell membrane‐derived vesicles as a novel therapeutic cancer vaccine. SHILAP Revista de lepidopterología. 1(2). 9 indexed citations
8.
Weigel, Cynthia, Melissa A. Maczis, Elisa N.D. Palladino, et al.. (2022). Sphingosine Kinase 2 in Stromal Fibroblasts Creates a Hospitable Tumor Microenvironment in Breast Cancer. Cancer Research. 83(4). 553–567. 16 indexed citations
9.
Yu, Xiaofei, Wenjie Liu, Shixian Chen, et al.. (2021). Immunologically programming the tumor microenvironment induces the pattern recognition receptor NLRC4-dependent antitumor immunity. Journal for ImmunoTherapy of Cancer. 9(1). e001595–e001595. 15 indexed citations
10.
Liu, Zheng, Chunqing Guo, Swadesh K. Das, et al.. (2021). Engineering T Cells to Express Tumoricidal MDA-7/IL24 Enhances Cancer Immunotherapy. Cancer Research. 81(9). 2429–2441. 12 indexed citations
11.
Wang, Juan, Chunqing Guo, Xiang‐Yang Wang, & Hu Yang. (2020). “Double-punch” strategy for delivery of viral immunotherapy with prolonged tumor retention and enhanced transfection efficacy. Journal of Controlled Release. 329. 328–336. 15 indexed citations
12.
Guo, Chunqing, Shixian Chen, Wenjie Liu, et al.. (2019). Immunometabolism: A new target for improving cancer immunotherapy. Advances in cancer research. 143. 195–253. 36 indexed citations
13.
He, Hongliang, Chunqing Guo, Jing Wang, et al.. (2018). Leutusome: A Biomimetic Nanoplatform Integrating Plasma Membrane Components of Leukocytes and Tumor Cells for Remarkably Enhanced Solid Tumor Homing. Nano Letters. 18(10). 6164–6174. 130 indexed citations
14.
Akiel, Maaged, Chunqing Guo, Xia Li, et al.. (2017). IGFBP7 Deletion Promotes Hepatocellular Carcinoma. Cancer Research. 77(15). 4014–4025. 50 indexed citations
15.
Guo, Chunqing, John R. Subjeck, & Xiang‐Yang Wang. (2017). Creation of Recombinant Chaperone Vaccine Using Large Heat Shock Protein for Antigen-Targeted Cancer Immunotherapy. Methods in molecular biology. 1709. 345–357. 7 indexed citations
16.
Yu, Xiaofei, Hongxia Wang, Xia Li, et al.. (2016). Activation of the MDA-5–IPS-1 Viral Sensing Pathway Induces Cancer Cell Death and Type I IFN-Dependent Antitumor Immunity. Cancer Research. 76(8). 2166–2176. 33 indexed citations
17.
Robertson, Chadia L., Jyoti Srivastava, Ayesha Siddiq, et al.. (2014). Genetic Deletion of AEG-1 Prevents Hepatocarcinogenesis. Cancer Research. 74(21). 6184–6193. 44 indexed citations
18.
Guo, Chunqing, Fanlei Hu, Huanfa Yi, et al.. (2014). Myeloid-derived suppressor cells have a proinflammatory role in the pathogenesis of autoimmune arthritis. Annals of the Rheumatic Diseases. 75(1). 278–285. 122 indexed citations
19.
Yu, Xiaofei, Chunqing Guo, Huanfa Yi, et al.. (2013). A Multifunctional Chimeric Chaperone Serves as a Novel Immune Modulator Inducing Therapeutic Antitumor Immunity. Cancer Research. 73(7). 2093–2103. 33 indexed citations
20.
Guo, Chunqing, Huanfa Yi, Xiaofei Yu, et al.. (2012). In Situ Vaccination with CD204 Gene-Silenced Dendritic Cell, not Unmodified Dendritic Cell, Enhances Radiation Therapy of Prostate Cancer. Molecular Cancer Therapeutics. 11(11). 2331–2341. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026